Status:
COMPLETED
Comparing 68Ga-CTR-FAPI and 18F-FDG PET/ CT in Cancer Detection
Lead Sponsor:
Lanzhou University Second Hospital
Conditions:
Tumors
PET / CT
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to compare the diagnostic efficacy of 68Ga-CTR-FAPI PET/CT and 18F-FDG PET/CT in various malignant tumors
Detailed Description
This study recruited malignant tumor patients diagnosed by histopathology and imaging at the Nuclear Medicine Department of Lanzhou University Second Hospital from July 2024 to March 2025. The enrolle...
Eligibility Criteria
Inclusion
- (a) Age ≥ 18 years old; (b) Suspected or newly diagnosed malignant tumors, evaluating the therapeutic effect of the tumor, or discovering recurrence/metastasis; (c) Obtain approval from oncologists and agree to undergo 18F-FDG and 68Ga-CTR-FAPI PET/CT scans within one week.
Exclusion
- (a) Pregnancy or lactation period; (b) Claustrophobia. (c) Serious health problems: such as severe heart, liver and kidney dysfunction, diseases that affect the metabolism or clearance of imaging agents.
Key Trial Info
Start Date :
July 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 5 2025
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT06945432
Start Date
July 1 2024
End Date
April 5 2025
Last Update
April 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Second Hospital of Lanzhou University
Lanzhou, Gansu, China, 730030